{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:05:03Z","timestamp":1784005503181,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Mast cells (MCs) are myeloid cells of the innate immune system. As a first line of defense, they fulfill effector functions and immune modulatory properties. Upon activation, they release pro-inflammatory mediators such as cytokines and proteases. It has been suggested that MCs may contribute to the development of liver fibrosis. However, investigating hepatic MC biology in mice is challenging due to low MC numbers and a lack of suitable detection techniques relying on MC proteins and their modifications. Here, we evaluated whether the expression strength of MC markers correlates with the degree of liver fibrosis in mice and aimed to determine the frequency and localization of hepatic MCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We applied both a toxic (DEN\/CCl\n                      <jats:sub>4<\/jats:sub>\n                      treatment) and a genetic (Mdr2\n                      <jats:sup>-\/-<\/jats:sup>\n                      mice) liver fibrosis model in C57BL\/6 mice to evaluate whether the expression strength of MC markers correlates with fibrosis severity in mice. Hepatic MCs were purified from fibrotic mouse livers by FACS, and MC-specific gene expression was verified by qPCR. Finally, we aimed to determine the frequency and localization of hepatic MCs by Molecular Cartography\u2122 in fibrotic liver sections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found significant correlations between liver fibrosis grade and the expression of several established MC markers. This was further supported by data analyses from patients with fibrosis and hepatocellular carcinoma (HCC) using publicly available transcriptomics datasets. FACS-isolated hepatic MCs were predominantly negative for Mast Cell Protease 5 (\n                      <jats:italic>Mcpt5<\/jats:italic>\n                      ) and occurred at a low frequency (approximately 1-2% of leukocytes). Molecular Cartography\u2122 revealed the spatial localization, expression signature, abundance (approximately 2 cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      ) and cellular environment of murine hepatic MCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>We demonstrated the existence of MCs in murine fibrotic livers and defined MC expression signatures that correlate with the strength of liver fibrosis. These findings will help to study MC biology in murine models of liver disease more effectively in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1852344","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:21:45Z","timestamp":1784002905000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification, purification and characterization of mast cells in murine liver fibrosis: optimized methods, expression signatures and correlation with severity"],"prefix":"10.3389","volume":"17","author":[{"given":"Christian","family":"Penners","sequence":"first","affiliation":[{"name":"Department of Medicine III, Uniklinik RWTH Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Otto","sequence":"additional","affiliation":[{"name":"Department of Medicine III, Uniklinik RWTH Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen K.","family":"Meurer","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), Uniklinik RWTH Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[{"name":"Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), Uniklinik RWTH Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Huber","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Molecular Immunology, Uniklinik RWTH Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Liedtke","sequence":"additional","affiliation":[{"name":"Department of Medicine III, Uniklinik RWTH Aachen","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111429","article-title":"Mast cells in liver fibrogenesis","volume":"8","author":"Weiskirchen","year":"2019","journal-title":"Cells"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri1782","article-title":"Integrated signalling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080407","article-title":"Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy","volume":"173","author":"Nigrovic","year":"2008","journal-title":"Am J Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.131","article-title":"Potential effector and immunoregulatory functions of mast cells in mucosal immunity","volume":"8","author":"Reber","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12964-025-02048-8","article-title":"TGF-beta1 induces mucosal mast cell genes and is negatively regulated by the IL-3\/ERK1\/2 axis","volume":"23","author":"Meurer","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200500211","article-title":"The proteome of mouse mucosal mast cell homologues: the role of transforming growth factor beta1","volume":"6","author":"Pemberton","year":"2006","journal-title":"Proteomics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230570","article-title":"Landscape of mast cell populations across organs in mice and humans","volume":"220","author":"Tauber","year":"2023","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030570","article-title":"Carboxypeptidase A3-A key component of the protease phenotype of mast cells","volume":"11","author":"Atiakshin","year":"2022","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000487538","article-title":"The staining of mast cells: a historical overview","volume":"176","author":"Ribatti","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27010392","article-title":"Increased intrahepatic mast cell density in liver cirrhosis due to MASLD and other non-infectious chronic liver diseases","volume":"27","author":"Ortiz-Lopez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(17)33764-2","article-title":"Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet","volume":"134","author":"Miyaoka","year":"2017","journal-title":"J Pharmacol Sci"},{"key":"B13","volume-title":"The Principles of Humane Experimental Technique","author":"Russell","year":"1959"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14 30 1","DOI":"10.1002\/0471141755.ph1430s66","article-title":"The DEN and CCl4 -induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma","volume":"66","author":"Uehara","year":"2014","journal-title":"Curr Protoc Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-05-2937","article-title":"Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice","volume":"66","author":"Katzenellenbogen","year":"2006","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316670","article-title":"Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis","volume":"68","author":"Liao","year":"2019","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11248-007-9153-4","article-title":"Mast cell-specific Cre\/loxP-mediated recombination in vivo","volume":"17","author":"Scholten","year":"2008","journal-title":"Transgenic Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","article-title":"A global double-fluorescent Cre reporter mouse","volume":"45","author":"Muzumdar","year":"2007","journal-title":"Genesis"},{"key":"B20","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am J Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.12.1092","article-title":"Update on mast cell biology","volume":"155","author":"Pahima","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158104","article-title":"Isolation of mature (peritoneum-derived) mast cells and immature (bone marrow-derived) mast cell precursors from mice","volume":"11","author":"Meurer","year":"2016","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1797","article-title":"Transcriptomic cross-species analysis of chronic liver disease reveals consistent regulation between humans and mice","volume":"6","author":"Holland","year":"2022","journal-title":"Hepatol Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am J Pathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.03.025","article-title":"New inducible mast cell-deficient mouse model (Mcpt5\/Cma1(DTR))","volume":"551","author":"Sasaki","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.964887","article-title":"Exploring the role of mast cells in the progression of liver disease","volume":"13","author":"Huang","year":"2022","journal-title":"Front Physiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000798","article-title":"Retraction: Mast cells induce ductular reaction mimicking liver injury in mice through mast cell-derived transforming growth factor beta 1 signaling","volume":"81","author":"Kyritsi","year":"2024","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001403","article-title":"Retraction: Blocking H1\/H2 histamine receptors inhibits damage\/fibrosis in Mdr2-\/- mice and human cholangiocarcinoma tumorigenesis","volume":"82","author":"Kennedy","year":"2025","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/01478885.2021.1915934","article-title":"Toluidine blue staining of murine mast cells and quantitation by a novel, automated image analysis method using whole slide skin images","volume":"44","author":"Raja","year":"2021","journal-title":"J Histotechnol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103364","article-title":"Protocol to characterize mouse dural mast cells by flow cytometry and immunofluorescence","volume":"5","author":"Lin","year":"2024","journal-title":"STAR Protoc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab Anim"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(85)90169-0","article-title":"Mast cell differentiation and heterogeneity","volume":"6","author":"Befus","year":"1985","journal-title":"Immunol Today"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020309","article-title":"Lung mast cells have a high constitutive expression of carboxypeptidase A3 mRNA that is independent from granule-stored CPA3","volume":"10","author":"Siddhuraj","year":"2021","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/dad.0000000000002878","article-title":"Quantifying mast cell and eosinophil cellular density in skin biopsy tissue from adults with maculopapular cutaneous mastocytosis as compared with urticaria and normal skin: a retrospective histopathologic study","volume":"47","author":"King","year":"2025","journal-title":"Am J Dermatopathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.immuni.2012.07.003","article-title":"Developmental origin and functional specialization of mast cell subsets","volume":"37","author":"Gurish","year":"2012","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1852344\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:21:47Z","timestamp":1784002907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1852344\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1852344"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1852344","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"1852344"}}